GGrantIndex
← Leaderboards

Jason Randolph Andrews

Massachusetts General Hospital

$8,284,933
Attributed
$10,932,867
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY201325
$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,932,867 · 8

By mechanism

R01$7,215,387 · 3
DP2$1,970,897 · 1
R21$855,217 · 2
K01$548,640 · 1
K24$342,726 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisInfectionTransmission ProcessIncidenceSamplingScreeningCommunicable DiseasesBloodCommunitiesNovel StrategiesBrazilDiagnosisCollaborationsCountryDiagnosticEpidemicMycobacterium TuberculosisCause Of DeathCost EffectivenessCostPrisonsImprisonmentCase FindingSputum

Grant awards (26)

Novel tools for measuring typhoid vaccine impact$667,635
R01 · FY2025 · AI · contact PI
Strategies for tuberculosis control in prisons$634,909
R01 · FY2025 · AI · contact PI
Mentoring patient-oriented translational research in tuberculosis$170,802
K24 · FY2025 · AI · contact PI
Novel tools for measuring typhoid vaccine impact$756,045
R01 · FY2024 · AI · contact PI
Strategies for tuberculosis control in prisons$653,230
R01 · FY2024 · AI · contact PI
Mentoring patient-oriented translational research in tuberculosis$171,924
K24 · FY2024 · AI · contact PI
Strategies for tuberculosis control in prisons$637,666
R01 · FY2023 · AI · contact PI
Point-of-care pharmacogenomic testing to optimize isoniazid dosing for tuberculosis prevention$189,443
R21 · FY2023 · AI · contact PI
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission$154,815
R01 · FY2023 · AI · contact PI
Point-of-care pharmacogenomic testing to optimize isoniazid dosing for tuberculosis prevention$232,535
R21 · FY2022 · AI · contact PI
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission$150,718
R01 · FY2022 · AI · contact PI
Evaluation of a point-of-care immunochromatographic assay for enteric fever$141,776
R21 · FY2022 · AI
Strategies for tuberculosis control in prisons$655,282
R01 · FY2021 · AI · contact PI
Evaluation of a point-of-care immunochromatographic assay for enteric fever$291,463
R21 · FY2021 · AI
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission$153,373
R01 · FY2021 · AI · contact PI
Strategies for tuberculosis control in prisons$670,765
R01 · FY2020 · AI · contact PI
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmission$157,700
R01 · FY2020 · AI · contact PI
Strategies for tuberculosis control in prisons$622,457
R01 · FY2019 · AI · contact PI
Strategies for tuberculosis control in prisons$640,923
R01 · FY2018 · AI · contact PI
Strategies for tuberculosis control in prisons$659,869
R01 · FY2017 · AI · contact PI
Congregate air sampling for population-based detection of tuberculosis$1,970,897
DP2 · FY2016 · AI · contact PI
Network Models for Evaluating HIV-associated MDR TB transmission and control$137,160
K01 · FY2016 · AI · contact PI
Network Models for Evaluating HIV-associated MDR TB transmission and control$137,160
K01 · FY2015 · AI · contact PI
Network Models for Evaluating HIV-associated MDR TB transmission and control$137,160
K01 · FY2014 · AI · contact PI
Network Models for Evaluating HIV-associated MDR TB transmission and control$87,124
K01 · FY2013 · AI · contact PI
Network Models for Evaluating HIV-associated MDR TB transmission and control$50,036
K01 · FY2013 · AI · contact PI